Skip to main content

QNCX

Quince Therapeutics, Inc.

Company with tickers: QNCX

CIK
1662774
CUSIP
22053A107
Shares Outstanding
19,559,257
13F Activity (30d)
15 filings 15 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 30
Total Value: $660,861
Total Shares: 6,543,325

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 30 13F filers
Top Holder
27.1%
Dec 2023 → Mar 2026 · range 21.3% – 43.2%
of institutional value
Top 5
82.2%
Dec 2023 → Mar 2026 · range 60.9% – 82.2%
of institutional value
Top 10
95.1%
Dec 2023 → Mar 2026 · range 78.9% – 95.1%
of institutional value
HHI
1,773
Dec 2023 → Mar 2026 · range 1,052 – 2,270
Moderately concentrated

Quarterly Activity

vs Feb 28, 2026
New
30
Increased
0
Decreased
0
Sold Out
1
Unchanged
0
Holder count: +29
Institutional value: -11.7%
Shares held: +10.1%

Top New Positions

vs Feb 28, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Feb 28, 2026
Institution Previously Held Last Value (USD) Open
Showing 32 of 32
Export CSV
Holder Value (USD) % of 13F Shares Open